Back

30 days and one year impact of the antithrombotic treatment following TAVI

29 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Valvular disease Aortic valve disease ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Pauline Balagny

Bichat APHP Site of Paris Nord University Hospital, Paris (France)

26 More presentations in this session

Presentation thumbnail
Doctor K. Nagao (Kyoto, JP)
Abstract
Presentation thumbnail
Doctor E. Wypasek (Cracow, PL)
Abstract Slides
Presentation thumbnail
Doctor J. Lopez Aguilera (Cordoba, ES)
Abstract Slides
Presentation thumbnail
Doctor A. Mateescu (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Sir M. Abawi (Utrecht, NL)
Abstract

Access the full session

Session thumbnail
Poster session 5 - Valvular disease

The Event

Event poster

ESC Congress 2016

29 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Antithrombotic therapy during TAVI and peri-interventional management of antithrombotic therapy.
28 August 2022
thumbnail
Congress Presentation
TAVI durability
28 August 2020
thumbnail
Congress Presentation
Correlation of platelet inhibition and cerebral thromboembolic events, as expressed with number of high-intensity transient signals,during Transcatheter Aortic valve Implantation.
28 August 2020
thumbnail
Congress Presentation
The impact of chronic total occlusions in patient outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources